Dipti Kanabar
Impact in
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Ubiquitin and proteasome pathways 7
- Epigenetics and DNA Methylation 2
- Oncology 6
- Cancer-related Molecular Pathways 2
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Aaron Muth (16 shared papers)Vivek Gupta (12 shared papers)Snehal K. Shukla (10 shared papers)Vineela Parvathaneni (5 shared papers)Nishant S. Kulkarni (3 shared papers)Bhuvaneshwar Vaidya (2 shared papers)Seyoum Ayehunie (4 shared papers)Apoorva Sarode (2 shared papers)
- Journals
- Journal of Molecular Liquids (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Future Medicinal Chemistry (2 papers)Pharmaceutical Research (1 paper)Cancers (1 paper)
- Partner nations
- United StatesTaiwanEgypt
In The Last Decade
Dipti Kanabar
15 papers receiving 396 citations
Peers
Comparison fields: 5 of 75
- Pharmaceutical Science 124
- Biomaterials 137
- Molecular Medicine 18
- Pulmonary and Respiratory Medicine 114
- Toxicology 8
Countries citing papers authored by Dipti Kanabar
This map shows the geographic impact of Dipti Kanabar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dipti Kanabar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dipti Kanabar more than expected).
Fields of papers citing papers by Dipti Kanabar
This network shows the impact of papers produced by Dipti Kanabar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dipti Kanabar. The network helps show where Dipti Kanabar may publish in the future.
Co-authors
The 25 scholars most cited alongside Dipti Kanabar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 106 | |
| 2 | 2018 | 65 | |
| 3 | 2020 | 57 | |
| 4 | 2020 | 51 | |
| 5 | 2020 | 37 | |
| 6 | 2019 | 21 | |
| 7 | 2021 | 17 | |
| 8 | 2020 | 16 | |
| 9 | 2020 | 9 | |
| 10 | 2023 | 7 | |
| 11 | 2022 | 6 | |
| 12 | 2021 | 2 | |
| 13 | 2020 | 2 | |
| 14 | 2022 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2024 | 0 | |
| 17 | 2024 | 0 |
About Dipti Kanabar
Dipti Kanabar is a scholar working on Molecular Biology, Oncology, Epidemiology, Pulmonary and Respiratory Medicine and Biomaterials, having authored 17 papers that have together received 398 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (7 papers), Autophagy in Disease and Therapy (5 papers), Nanoparticle-Based Drug Delivery (3 papers), Inhalation and Respiratory Drug Delivery (3 papers), Drug Solubulity and Delivery Systems (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer-related Molecular Pathways (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Pharmaceutical Science (124 citations), Biomaterials (137 citations), Molecular Medicine (18 citations), Pulmonary and Respiratory Medicine (114 citations) and Toxicology (8 citations). Dipti Kanabar has collaborated with scholars based in United States, Taiwan and Egypt. Frequent co-authors include Aaron Muth, Vivek Gupta, Snehal K. Shukla, Vineela Parvathaneni, Nishant S. Kulkarni, Bhuvaneshwar Vaidya, Seyoum Ayehunie, Apoorva Sarode, Samir Mitragotri and Nitesh K. Kunda. Their work appears in journals such as Journal of Molecular Liquids, Bioorganic & Medicinal Chemistry Letters, Future Medicinal Chemistry, Pharmaceutical Research and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.